| 000 | 01512 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250513235534.0 | ||
| 264 | 0 | _c20010823 | |
| 008 | 200108s 0 0 eng d | ||
| 022 | _a1198-743X | ||
| 024 | 7 |
_a10.1046/j.1469-0691.2001.00220.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aManavathu, E K | |
| 245 | 0 | 0 |
_aIsolation and in vitro susceptibility to amphotericin B, itraconazole and posaconazole of voriconazole-resistant laboratory isolates of Aspergillus fumigatus. _h[electronic resource] |
| 260 |
_bClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases _cMar 2001 |
||
| 300 |
_a130-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAmphotericin B _xpharmacology |
| 650 | 0 | 4 |
_aAntifungal Agents _xpharmacology |
| 650 | 0 | 4 |
_aAspergillus fumigatus _xdrug effects |
| 650 | 0 | 4 | _aDrug Resistance, Microbial |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aItraconazole _xpharmacology |
| 650 | 0 | 4 |
_aMicrobial Sensitivity Tests _xmethods |
| 650 | 0 | 4 |
_aPyrimidines _xpharmacology |
| 650 | 0 | 4 |
_aTriazoles _xpharmacology |
| 650 | 0 | 4 | _aVoriconazole |
| 700 | 1 | _aAbraham, O C | |
| 700 | 1 | _aChandrasekar, P H | |
| 773 | 0 |
_tClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases _gvol. 7 _gno. 3 _gp. 130-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1469-0691.2001.00220.x _zAvailable from publisher's website |
| 999 |
_c11253017 _d11253017 |
||